Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Invested Capital (2016 - 2025)

Historic Invested Capital for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $538.4 million.

  • AtriCure's Invested Capital rose 218.0% to $538.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $538.4 million, marking a year-over-year increase of 218.0%. This contributed to the annual value of $463.8 million for FY2024, which is 242.81% down from last year.
  • Per AtriCure's latest filing, its Invested Capital stood at $538.4 million for Q3 2025, which was up 218.0% from $526.4 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Invested Capital ranged from a high of $548.5 million in Q3 2021 and a low of $385.1 million during Q2 2021
  • For the 5-year period, AtriCure's Invested Capital averaged around $499.2 million, with its median value being $516.7 million (2022).
  • The largest annual percentage gain for AtriCure's Invested Capital in the last 5 years was 7207.63% (2021), contrasted with its biggest fall of 762.34% (2021).
  • Over the past 5 years, AtriCure's Invested Capital (Quarter) stood at $494.7 million in 2021, then dropped by 5.63% to $466.9 million in 2022, then increased by 1.8% to $475.3 million in 2023, then fell by 2.43% to $463.8 million in 2024, then increased by 16.08% to $538.4 million in 2025.
  • Its Invested Capital stands at $538.4 million for Q3 2025, versus $526.4 million for Q2 2025 and $516.5 million for Q1 2025.